This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Anticoagulants or Inferior Vena Cava Filter?

Jeffrey W. Olin, DO; Jess R. Young, MD; Robert A. Graor, MD; William F. Ruschhaupt, MD; Edwin G. Beven, MD; Janet W. Bay, MD

Arch Intern Med. 1987;147(12):2177-2179.

Abstract
• There is a common belief that administration of anticoagulants to patients with brain tumors is contraindicated. Between 1982 and 1986, 50 patients with deep venous thrombosis and pulmonary emboli and brain tumors were examined and treated. Twenty-four patients received an inferior vena cava Greenfield filter and 25 patients were treated with anticoagulants. One patient was terminal and received no therapy. Patients in each group were similar with regard to age, sex, primary tumor, computed tomographic findings, and ultimate outcome. At the time of diagnosis, all patients had residual tumor and most had significant cerebral edema and midline shift. There were no complications in the group receiving Greenfield filters. One patient had a pulmonary embolus after the filter was placed and later required anticoagulant therapy. In the group receiving anticoagulants, one patient had focal intraventricular bleeding observed incidentally on computed tomographic scan one month after beginning anticoagulant therapy and was totally asymptomatic. One patient had gastrointestinal tract bleeding five days after beginning anticoagulant therapy with heparin sodium, and the therapy was therefore discontinued. No other patient had significant bleeding. In view of these findings, a reevaluation of anticoagulant therapy in patients with central nervous system tumors is warranted.

(Arch Intern Med 1987;147:2177-2179)

Author Affiliations
From the Departments of Peripheral Vascular Disease (Drs Olin, Young, Graor, and Ruschhaupt), Vascular Surgery (Dr Beven), and Neurosurgery (Dr Bay), Cleveland Clinic Foundation.

Footnotes
Accepted for publication Aug 31, 1987.

Reprint requests to Department of Peripheral Vascular Disease, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44106 (Dr Olin).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Need for Inferior Vena Cava Filters in Cancer Patients: A Surrogate Marker for Poor Outcome
Barginear et al.
CLIN APPL THROMB HEMOST 2009;15:263-269.
ABSTRACT  

American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer
Lyman et al.
JCO 2007;25:5490-5505.
ABSTRACT | FULL TEXT  

Thrombolytic Therapy for Massive Pulmonary Embolism in a Patient With a Known Intracranial Tumor
Han et al.
J Intensive Care Med 2006;21:240-245.
ABSTRACT  

Management of Venous Thromboembolism in Patients With Primary and Metastatic Brain Tumors
Gerber et al.
JCO 2006;24:1310-1318.
ABSTRACT | FULL TEXT  

Anticoagulation or Inferior Vena Cava Filter Placement for Patients With Primary Intracerebral Hemorrhage Developing Venous Thromboembolism?
Kelly et al.
Stroke 2003;34:2999-3005.
ABSTRACT | FULL TEXT  

Vena Caval Filters: A Review for Intensive Care Specialists
Streiff
J Intensive Care Med 2003;18:59-79.
ABSTRACT  

Vena caval filters: a comprehensive review
Streiff
Blood 2000;95:3669-3677.
ABSTRACT | FULL TEXT  

Cancer, Coagulation, and Anticoagulation
Letai and Kuter
The Oncologist 1999;4:443-449.
ABSTRACT | FULL TEXT  

Venous Thromboembolism and Malignant Brain Tumors: A Review
Jubelirer
CLIN APPL THROMB HEMOST 1996;2:130-136.
ABSTRACT  

Clinical Presentation of Thrombosed Greenfield Filters
Kolachalam and Julian
VASC ENDOVASCULAR SURG 1990;24:666-670.
ABSTRACT